Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation

JACC: Heart Failure - Tập 5 Số 8 - Trang 552-560 - 2017
Neal A. Chatterjee1,2, Claudia U. Chae1, Eun-Jung Kim2, M. Vinayaga Moorthy2, David Conen3,2, Roopinder K. Sandhu4, Nancy R. Cook2, I‐Min Lee5,2, Christine M. Albert6,2
1Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
2Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
3Department of Medicine, University Hospital, Basel, Switzerland
4Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
5Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
6Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Conen, 2011, Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation, JAMA, 305, 2080, 10.1001/jama.2011.659

Schnabel, 2015, 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study, Lancet, 386, 154, 10.1016/S0140-6736(14)61774-8

Piccini, 2014, Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke, Eur Heart J, 35, 250, 10.1093/eurheartj/eht483

Odutayo, 2016, Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis, BMJ, 354, i4482, 10.1136/bmj.i4482

Santhanakrishnan, 2016, Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction, Circulation, 133, 484, 10.1161/CIRCULATIONAHA.116.022835

Lee, 2005, Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial, JAMA, 294, 56, 10.1001/jama.294.1.56

McKee, 1971, The natural history of congestive heart failure: the Framingham study, N Engl J Med, 285, 1441, 10.1056/NEJM197112232852601

Fried, 1991, The Cardiovascular Health Study: design and rationale, Ann Epidemiol, 1, 263, 10.1016/1047-2797(91)90005-W

Chae, 2012, Vitamin E supplementation and the risk of heart failure in women, Circ Heart Fail, 5, 176, 10.1161/CIRCHEARTFAILURE.111.963793

Vermond, 2015, Incidence of Atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands, J Am Coll Cardiol, 66, 1000, 10.1016/j.jacc.2015.06.1314

Chiuve, 2011, Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women, JAMA, 306, 62

Potpara, 2013, Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study, Eur J Heart Fail, 15, 415, 10.1093/eurjhf/hft004

Schnabel, 2013, Risk assessment for incident heart failure in individuals with atrial fibrillation, Eur J Heart Fail, 15, 843, 10.1093/eurjhf/hft041

Pandey, 2017, Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation, J Am Coll Cardiol HF, 5, 44

Conen, 2009, Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women, Circulation, 119, 2146, 10.1161/CIRCULATIONAHA.108.830042

Schoen, 2012, Type 2 diabetes mellitus and risk of incident atrial fibrillation in women, J Am Coll Cardiol, 60, 1421, 10.1016/j.jacc.2012.06.030

Tedrow, 2010, The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation: the WHS (Women's Health Study), J Am Coll Cardiol, 55, 2319, 10.1016/j.jacc.2010.02.029

Britton, 2009, Normal systolic blood pressure and risk of heart failure in US male physicians, Eur J Heart Fail, 11, 1129, 10.1093/eurjhf/hfp141

Ko, 2016, Level of blood pressure control and cardiovascular events: SPRINT criteria versus the 2014 hypertension recommendations, J Am Coll Cardiol, 67, 2821, 10.1016/j.jacc.2016.03.572

Kitzman, 2016, The HFpEF obesity phenotype: the elephant in the room, J Am Coll Cardiol, 68, 200, 10.1016/j.jacc.2016.05.019

Chugh, 2016, The C of CHADS: historical perspective and clinical applications for anticoagulation in patients with nonvalvular atrial fibrillation and congestive heart failure, Int J Cardiol, 224, 431, 10.1016/j.ijcard.2016.09.025